GNRO.PA
Price:
$0.0454
Market Cap:
$1.34M
GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody, which has completed Phase IIb clinical trial for multiple sclerosis; and is in Phase IIa to treat type 1 diabetes, as well as is in Phase I for the treatment of chronic inflammatory demyelinating polyneuropathy. It has cooperative research and development agreements with The National Institute of Neurological Disorders and Stroke to develop novel therapeutic antibodies for the treatment of amyotrophic lateral sclerosis; and Academic labs to develop inflammatory psychosis, as well as...[Read more]
Industry
Biotechnology
IPO Date
2016-04-15
Stock Exchange
PAR
Ticker
GNRO.PA
According to GeNeuro S.A.’s latest financial reports and current stock price. The company's current Current Ratio is 0.37. This represents a change of -82.75% compared to the average of 2.17 of the last 4 quarters.
The mean historical Current Ratio of GeNeuro S.A. over the last ten years is 2.37. The current 0.37 Current Ratio has changed 1.48% with respect to the historical average. Over the past ten years (40 quarters), GNRO.PA's Current Ratio was at its highest in in the June 2020 quarter at 5.04. The Current Ratio was at its lowest in in the June 2012 quarter at 0.
Average
2.37
Median
2.60
Minimum
0.37
Maximum
4.30
Discovering the peaks and valleys of GeNeuro S.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 396.53%
Maximum Annual Current Ratio = 4.30
Minimum Annual Increase = -86.40%
Minimum Annual Current Ratio = 0.37
| Year | Current Ratio | Change |
|---|---|---|
| 2023 | 0.37 | -86.40% |
| 2022 | 2.75 | -14.60% |
| 2021 | 3.22 | -2.31% |
| 2020 | 3.29 | 396.53% |
| 2019 | 0.66 | -66.00% |
| 2018 | 1.95 | 5.88% |
| 2017 | 1.84 | -35.65% |
| 2016 | 2.86 | 16.39% |
| 2015 | 2.46 | -42.88% |
| 2014 | 4.30 | 12.30% |
The current Current Ratio of GeNeuro S.A. (GNRO.PA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.11
5-year avg
2.06
10-year avg
2.37
GeNeuro S.A.’s Current Ratio is less than Abivax S.A. (0.77), less than OSE Immunotherapeutics S.A. (3.46), less than Sensorion S.A. (4.90), greater than GenSight Biologics S.A. (0.24), less than Transgene S.A. (0.54),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.77 | $7.35B | |
| 3.46 | $112.67M | |
| 4.90 | $91.64M | |
| 0.24 | $19.65M | |
| 0.54 | $121.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeNeuro S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GeNeuro S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is GeNeuro S.A.'s Current Ratio?
How is the Current Ratio calculated for GeNeuro S.A. (GNRO.PA)?
What is the highest Current Ratio for GeNeuro S.A. (GNRO.PA)?
What is the 3-year average Current Ratio for GeNeuro S.A. (GNRO.PA)?
What is the 5-year average Current Ratio for GeNeuro S.A. (GNRO.PA)?
How does the current Current Ratio for GeNeuro S.A. (GNRO.PA) compare to its historical average?